Call For Abstracts

Call For Abstracts

Abstract submission opens in October 2015 

The Scientific Committee for the 2016 IASLC Asia Pacific Lung Cancer Conference (APLCC 2016) welcomes the submission of scientific abstracts.

Authors are requested to submit abstracts in the following areas of interest:

  • Biology
  • Medical oncology
  • Combined modality
  • Epidemiology
  • Imaging / staging
  • Immunology/Immunotherapy
  • Radiotherapy
  • Nursing & supportive care
  • Pathology
  • Pulmonology
  • Radiology / screening
  • Smoking cessation
  • Surgery

Submission Guidelines

  • Abstracts will only be accepted electronically through the conference website
  • Abstracts will be accepted in English only
  • Abstracts should not exceed 300 words in length and must be in Microsoft word format (.doc)
  • Abstracts must be structured with the following:
    5.)Summary / conclusion
  • A maximum of 2 images (graph / table / picture) may be included
  • There is no limit to the number of abstracts you may submit (an individual may not be offered
    more than 2 oral presentations)
  • All abstracts accepted by the Scientific Committee will be published in abstract book or in the USB
    provided to attendees and it is mandatory to agree to this at the time of submission
  • All authors are liable for the full conference registration fee
  • The respective authors and APLCC 2016 Scientific Committee enjoy copyright to the accepted abstracts

Encore Abstracts Policy

If the material has already been published or has been presented at other scientific meeting (unless the presentation is in a small local meeting), then the material should not be presented again in APLCC 2016. However, if the study is analyzed from another angle which shows new information or results, then submission to APLCC 2016 is permissible.

Selection of Abstracts

The Scientific committee will evaluate all abstracts submitted and determine the selection for either oral or poster presentation at APLCC 2016. Official notification of acceptance or rejection of an abstract will be emailed to the corresponding person on 15 March 2016.

Criteria for selection shall be based upon:

  • Conformity to the purpose of the respective
  • Originality
  • Content and presentation quality

Guideline for Trial in progress abstract submissions

Trial in progress abstracts in all phases of clinical research (phase I to III) may be submitted to APLCC 2016.

It is expected that abstracts submitted as Trial in progress are ongoing trials that have not reached any protocol-specific endpoints for analysis and consequently will only require the completion of 2 sections: Background and Trial design.

Please note the following:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of
    7 March 2016   5.00 p.m. (GMT+7).
  • Abstracts including results or preliminary data will be rejected.
  • Abstracts will be reviewed by the APLCC 2016 Scientific Committee and considered on the merits of the
    scientific and clinical rationale of the trial.
  • Trial in Progress abstracts will not be considered for oral presentation.


Abstract submission deadline 7 March 2016   5.00 p.m. (GMT+7)
Author notification of acceptance 15 March 2016
Author registration deadline 30 March 2016